BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3684 related articles for article (PubMed ID: 19659433)

  • 41. Childhood immunization guidelines: current and future.
    Zimmerman RK; Burns IT
    Prim Care; 1994 Dec; 21(4):693-715. PubMed ID: 7855158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
    Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
    Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
    Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):997-1001. PubMed ID: 19763075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adult immunization].
    Beytout J
    Bull Acad Natl Med; 2003; 187(8):1463-74; discussion 1474-6. PubMed ID: 15146578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Adult immunization in France: an update].
    Beytout J; Laurichesse H
    Rev Prat; 2004 Mar; 54(5):499-505. PubMed ID: 15176507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The childhood vaccination program. Background, status and future].
    Plesner AM; Rønne T
    Ugeskr Laeger; 1994 Dec; 156(50):7497-503. PubMed ID: 7839512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services.
    Berman S; Armon C; Todd J
    Pediatrics; 2005 Dec; 116(6):1474-9. PubMed ID: 16322173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Routine immunization of infants in the Canton of Zurich].
    Vranjes N; Gyurech D; Schilling J; Gugelmann R; Steffen R
    Schweiz Med Wochenschr; 1996 Jan; 126(1-2):22-6. PubMed ID: 8571109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):846-51. PubMed ID: 17403861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. National vaccination coverage among adolescents aged 13-17 years--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(34):885-8. PubMed ID: 17728694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Child vaccination, part 2: childhood vaccination procedures.
    Zimmerman RK; Burns IT
    J Fam Pract; 2000 Sep; 49(9 Suppl):S34-9; quiz S40. PubMed ID: 11032191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The preteen visit: an opportunity for prevention.
    Campos-Outcalt D
    J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of childhood diseases through vaccination.
    Belcher EA
    Neonatal Netw; 1993 Apr; 12(3):35-9. PubMed ID: 8474410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 185.